Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-13

FDA Approved: CARBAMAZEPINE — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved Upsher-Smith Laboratories' Original Application for carbamazepine (generic) under ANDA213311.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbamazepine (Carbamazepine)

Snippet

ORIG AP for CARBAMAZEPINE (CARBAMAZEPINE)